We recently reported claims that the DEA has granted unnamed private pharmaceutical companies license to grow cannabis for experimental purposes. Now, the Sacramento News & Review on Dec. 19 cites a report from the Union of Medical Marijuana Patients to the effect that the United States government holds a patent on the use of cannabinoids as "antioxidants and neuroprotectants"—specifically, the Department of Health & Human Services holds Patent #6630507, as documented at the US Patent & Trademark Office.
Recent comments
9 weeks 5 days ago
13 weeks 6 days ago
15 weeks 3 days ago
15 weeks 4 days ago
27 weeks 6 days ago
33 weeks 4 days ago
44 weeks 4 days ago
45 weeks 4 days ago
47 weeks 1 day ago
47 weeks 4 days ago